[ad#The Buzz Sponsor Ad]

Biomedical benefits of macroalgae study in Chile

June 12, 2013
AlgaeIndustryMagazine.com

Ahnfeltia plicata, the landlady's wig, is a species of red alga.

Ahnfeltia plicata, the landlady’s wig, is a species of red alga. Courtesy: Gabriele Kothe-Heinrich, Wikipedia.org

Analia Murias reports in Chile’s fis.com that researchers at the University of Santiago de Chile (USACH) are studying three species of macroalgae: Mazzaella laminarioides, Sarcothalia crispata and Ahnfeltia plicata – in the Region of Magallanes – to develop antibacterial patches and gastric juice resistant drugs.

The study, entitled Soluble Algal Polysaccharides from the Magallanes Region, is a project funded by Chile’s Department of Scientific and Technological Research (Dicyt) of the Vice-Rectory for Research, Development and Innovation, and is directed by Betty Matsuhiro, a researcher at the Department of Environmental Sciences of the Faculty of Chemistry and Biology of USACH.

Algal polysaccharides are used primarily in the food industry. “With this new project, the idea is to innovate in the use of this natural resource and develop products with higher added value, which can be used in biomedicine,” said Matsuhiro.

During the first stage of the study, researchers at the University of Magallanes, and at the Institute of Ecology and Biodiversity, will be in charge of collecting algae. Later, the polysaccharide extraction, their chemical modification and conjugation with synthetic polymers will be developed.

At a later stage the encapsulation of drugs will be analyzed, according to USACH. An application of the polysaccharides under study is their use to encapsulate drugs and prevent them from disintegrating with the acidity of gastric juices. Since they are biodegradable and biocompatible, polysaccharides are helpful for use with antibacterial drugs.

Read More

More Buzz…

HOME Algae Industry Jobs

Copyright ©2010-2013 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Algatech has announced the opening of Algatech Inc., a New York City-based subsidiary created to serve the North American market. The company has appointed Ken Seguine to...
WesTech Engineering, Inc. and Utah State University’s Sustainable Waste-to-Bioproducts Engineering Center (SWBEC) are jointly engaged in developing processes for more eff...
David Erickson writes in the (Montana) Missoulian that Clearas Water Recovery, a Missoula tech company formed eight years ago, has developed a patented process to use alg...
Will Yeates reports in DailyPlanet.com that an urban “algae farm” producing low-carbon protein and bio-fuel is one of the highlights on show this week at the future energ...
Washington State University researchers have developed a biofilm reactor to grow algae more efficiently, and make the algae more viable for several industries, including ...
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating arthritis. This is based on a polysaccharide, a long-c...
Sex self-destruction represents a fascinating new scientific mystery that includes climate chaos, ghost forests, temperature spikes, fierce storms, colossal nutrient coll...
Colorado State University scientists and Arizona State University’s Arizona Center for Algae Technology and Innovation are partners in a three-year grant of up to $3.5 mi...
Portuguese microalgae producer, Allmicroalgae Natural Products S.A., has recently begun production of Chlorella vulgaris and other microalgae species via fermentation, wh...
Jeff Gelsky writes in Meat+Poultry that Corbion executives have given insights on how its September 29 acquisition of TerraVia Holdings Inc., an algae-based ingredients c...
The Utah Science Technology and Research (USTAR) initiative, a technology-based economic development program funded by the state of Utah, has awarded a $175,320 grant for...
Israeli-based Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health New Zealand, Ltd. (Supreme) to supply the rapidly growing markets in Ch...